GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Biotech Ltd (BOM:524717) » Definitions » Enterprise Value

Titan Biotech (BOM:524717) Enterprise Value : ₹6,137 Mil (As of Jan. 18, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Titan Biotech Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Titan Biotech's Enterprise Value is ₹6,137 Mil. Titan Biotech's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ₹315 Mil. Therefore, Titan Biotech's EV-to-EBIT ratio for today is 19.49.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Titan Biotech's Enterprise Value is ₹6,137 Mil. Titan Biotech's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ₹353 Mil. Therefore, Titan Biotech's EV-to-EBITDA ratio for today is 17.38.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Titan Biotech's Enterprise Value is ₹6,137 Mil. Titan Biotech's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₹1,689 Mil. Therefore, Titan Biotech's EV-to-Revenue ratio for today is 3.63.


Titan Biotech Enterprise Value Historical Data

The historical data trend for Titan Biotech's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Biotech Enterprise Value Chart

Titan Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 596.14 1,663.89 2,254.10 1,663.19 4,419.51

Titan Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,944.29 3,384.81 4,419.51 5,039.20 5,792.23

Competitive Comparison of Titan Biotech's Enterprise Value

For the Biotechnology subindustry, Titan Biotech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Titan Biotech's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Titan Biotech's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Titan Biotech's Enterprise Value falls into.



Titan Biotech Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Titan Biotech's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as

Titan Biotech's Enterprise Value for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Titan Biotech  (BOM:524717) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Titan Biotech's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6137.237/314.972
=19.49

Titan Biotech's current Enterprise Value is ₹6,137 Mil.
Titan Biotech's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹315 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Titan Biotech's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=6137.237/353.157
=17.38

Titan Biotech's current Enterprise Value is ₹6,137 Mil.
Titan Biotech's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹353 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Titan Biotech's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6137.237/1689.033
=3.63

Titan Biotech's current Enterprise Value is ₹6,137 Mil.
Titan Biotech's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,689 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Titan Biotech Enterprise Value Related Terms

Thank you for viewing the detailed overview of Titan Biotech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Biotech Business Description

Traded in Other Exchanges
N/A
Address
903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi, IND, 110034
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.

Titan Biotech Headlines

No Headlines